Highlights From Biogen Idec's (BIIB) Q2 Conference Call: Guides In-line for FY
Tweet Send to a Friend
This morning, Biogen Idec (Nasdaq: BIIB) reported Q2 EPS of $0.75, ex-items, 7 cents better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
